Related Experiment Video
Updated: Jul 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Patient-driven second opinions in oncology: a review
1Department of Integrated Medicine, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL 33431, United States.
Introduction:
Patient-initiated second opinions have become increasingly common in recent years. However, the frequency, motivations and advantages/disadvantages of this approach remain unclear. This study assessed the incidence and impact of patient-initiated second opinions in oncology patients.
Methods:
Literature searches of PubMed and Google Scholar were performed to identify peer-reviewed publications on patient-initiated second opinions in oncology patients published between 06/01/2004 and 06/01/2024. Selected publications evaluated the frequency, patient characteristics and motivating factors of patient-initiated second opinions and their impact on diagnoses, treatment, prognoses and patient satisfaction.
Results:
Sixty peer-reviewed publications were included in the analysis. Data showed highly variable rates of second-opinion seeking. Younger age, female gender, higher educational level, advanced disease, socioeconomic status and having health insurance were associated with an increased likelihood of this approach. The most common patient-reported reasons for seeking a second opinion were to gain more information, seek reassurance, access expert guidance, and check the accuracy of proposed treatments. Patient-initiated second opinions led to changes in diagnosis, treatment, or prognosis in up to 69% of cases and a greater likelihood of guideline-compliant recommendations; however, wide variability in reported rates precludes drawing firm conclusions. Patient satisfaction with second-opinion consultations was high and these were deemed helpful and reassuring in most cases.
Conclusion:
Increasing numbers of cancer patients are seeking second opinions, and these may have a considerable impact on diagnoses, outcomes and patient satisfaction. Improved patient education and further research regarding the impact of patient-initiated second opinions and barriers to access would be beneficial.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Standards of Care II
Targeted Cancer Therapies
There are several types of targeted therapies against specific...